Samuel Menghistu

Samuel Menghistu has worked at a variety of companies since 2010. Samuel began their career as a Student Employee in the Investment Banking Division of Credit Suisse. Samuel then worked as an Intern in the Mergers & Acquisitions (M&A) department of Rothschild in 2012. In 2011, they were an Intern in the Valuation & Strategy department of PwC. In 2013, they moved to BNP Paribas and worked as a Student Employee in the M&A department. From 2015 to 2017, they worked as an Analyst in the M&A, Corporate & Leveraged Finance department of IKB Deutsche Industriebank AG. In 2017, they became an Associate at ACXIT Capital Partners. In 2019, they were promoted to Vice President at Berenberg. In 2020, they became a Co-Founder at Bloomwell Group, where they focused on creating a patient-centric, direct-to-consumer approach to healthcare. Samuel is currently the Chief Financial Officer (CFO) of MAYD: MEDS AT YOUR DOORSTEP.

Samuel Menghistu obtained a Bachelor of Science in Wirtschaftswissenschaften from Goethe University between 2007 and 2011. Samuel then pursued a Master of Science in Management from the University of Mannheim between 2011 and 2014. During this time, they also took courses in Business Administration at San Diego State University in 2013.